Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation?

A Marrelli, P Cipriani, V Liakouli, F Carubbi… - Autoimmunity …, 2011 - Elsevier
Angiogenesis is the formation of new blood vessels from existing vessels. During RA new
blood vessels can maintain the chronic inflammatory state by transporting inflammatory cells to …

International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid …

…, E Bartoloni-Bocci, O Berardicurti, F Carubbi… - Autoimmunity …, 2017 - Elsevier
Autoimmune diseases are a complex set of diseases characterized by immune system
activation and, although many progresses have been done in the last 15 years, several unmet …

Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study

F Carubbi, P Cipriani, A Marrelli, PD Benedetto… - Arthritis research & …, 2013 - Springer
Introduction Primary Sjögren’s syndrome (pSS) is an autoimmune disorder affecting
exocrine glands; however, a subgroup of pSS patients experience systemic extra-glandular …

Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers

…, D Iacono, F Ciccia, V Liakouli, G Guggino, F Carubbi… - BMC medicine, 2016 - Springer
Background Adult-onset Still’s disease (AOSD) is rare inflammatory disease of unknown
etiology that usually affects young adults. The more common clinical manifestations are spiking …

Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study

…, M Isola, C Baldini, R Priori, EB Bocci, F Carubbi… - Journal of …, 2014 - Elsevier
Objectives To define the biomarkers associated with lymphoproliferation in primary Sjögren’s
syndrome (pSS) by distinguishing in separate groups the two best-recognized non-…

Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units

F Carubbi, L Salvati, A Alunno, F Maggi, E Borghi… - Scientific reports, 2021 - nature.com
The coronavirus 2019 disease (COVID-19) is characterised by a heterogeneous clinical
presentation, a complex pathophysiology and a wide range of imaging findings, depending on …

2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis

…, L Barbosa, C Boström, B Boteva, F Carubbi… - Annals of the …, 2020 - ard.bmj.com
To update the European League Against Rheumatism (EULAR) recommendations for the role
of the nurse in the management of chronic inflammatory arthritis (CIA) using the most up to …

Methotrexate: an old new drug in autoimmune disease

P Cipriani, P Ruscitti, F Carubbi, V Liakouli… - Expert Review of …, 2014 - Taylor & Francis
Methotrexate (MTX) is currently considered, among disease-modifying anti-rheumatic drugs
(DMARDs), the ‘anchor-drug’ in the treatment of rheumatoid arthritis. In the last 25 years, …

Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin

A Alunno, F Carubbi, J Rodríguez-Carrio - RMD open, 2020 - rmdopen.bmj.com
Some of the articles being published during the severe acute respiratory syndrome–coronavirus
(SARS-CoV)-2 pandemic highlight a link between severe forms of coronavirus disease …

Interstitial lung disease in systemic sclerosis: current and future treatment

…, P Ruscitti, P Di Benedetto, F Carubbi… - Rheumatology …, 2017 - Springer
Systemic sclerosis (SSc) has the highest fatality rate among connective tissue diseases and
is characterized by vascular damage, inflammation and fibrosis of the skin and various …